Thu, August 11, 2022
Wed, August 10, 2022
Tue, August 9, 2022
Mon, August 8, 2022

John Abbott Maintained (ARCT) at Buy with Decreased Target to $98 on, Aug 10th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-98-on-aug-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

John Abbott of Wells Fargo, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Buy with Decreased Target from $105 to $98 on, Aug 10th, 2022.

John has made no other calls on ARCT in the last 4 months.



There are 4 other peers that have a rating on ARCT. Out of the 4 peers that are also analyzing ARCT, 2 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joel Beatty of "Baird" Upgraded from Sell to Hold and Decreased Target to $18 on, Wednesday, May 11th, 2022
  • Ed Arce of "HC Wainwright & Co." Maintained at Hold with Decreased Target to $19 on, Tuesday, May 10th, 2022


These are the ratings of the 2 analyists that currently disagree with John


  • Pete Stravropoulos of "Cantor Fitzgerald" Initiated at Buy and Held Target at $39 on, Tuesday, July 19th, 2022
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $8 on, Tuesday, May 24th, 2022

Publication Contributing Sources